May 19, 2020 by Chain Drug Review
Brett Briggs, COVID-19, Doug McMillion, Walmart
Business, Featured Articles, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart posted strong sales gains across its businesses in the first quarter, with demand driven by the COVID-19 outbreak. Unprecedented demand for products across multiple categories led to strong top-line results. But certain incremental costs negatively affected operating income, including costs associated with enhanced wages and benefits as well as safety and
April 30, 2020 by Jeffrey Woldt
COVID-19 testing, Doug McMillion, Heyward Donigan, Larry Merlo, NACDS, President Trump, Richard Ashworth
Opinion

Entrenched assumptions about the role of community pharmacy are being uprooted by the COVID-19 crisis, and leaders of five of the nation’s largest retailers accelerated the process earlier this week during a meeting with President Trump and the Coronavirus Task Force at the White House. The executives were there to lend support to the public-private
April 28, 2020 by Chain Drug Review
COVID-19 testing, Doug McMillion, Heyward Donigan, Larry Merlo, NACDS, Richard Ashworth, Rodney McMullen
Leading Headlines, Pharmacy

WASHINGTON – At the White House yesterday, NACDS chairman of the board Richard Ashworth, president of Walgreens, lauded the dedication and professionalism of pharmacists serving in communities throughout the nation. Remarks of Ashworth and of the leaders of four other NACDS member companies signaled ongoing expansion of COVID-19 testing through public-private partnerships, and were delivered
February 18, 2020 by Chain Drug Review
Doug McMillion, Sam's Club, Walmart
Business, Featured Articles, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart reported sales of $141.7 billion for the fourth quarter of fiscal 2020, an increase of $12.9 billion, or about 2.1%, over the prior year period. Earnings and sales fell short of analysts expectations, however, and Walmart said that holiday sales were softer than expected. Walmart president and CEO Doug McMillon said
February 17, 2020 by Jeffrey Woldt
Doug McMillion, Jamie Dimon
February 17, 2020, Opinion

If Karl Marx was right when he asserted that, above all else, economic factors determine the course of history, there may finally be some real hope that the issue of climate change will be addressed with the seriousness it requires. Business and financial leaders are stepping up to the challenge, giving every indication that the
November 14, 2019 by Chain Drug Review
Doug McMillion, Ga, Walmart, Walmart Health center in Dallas
Business, Leading Headlines, Retail News

BENTONVILLE, Ark. — Walmart on Thursday reported that its third-quarter revenue rose 2.5% to $128 billion on strong sales at its U.S. stores and websites. U.S. comparable sales increased 3.2%, extending a four-year streak of quarterly gains. U.S. e-commerce sales increased 41%, driven by gains in Walmart’s grocery business, which is gaining competitiveness thanks to
September 6, 2019 by Chain Drug Review
CVS, Doug McMillion, Kroger Co., Walgreens, Wegmans
Leading Headlines, Retail News

NEW YORK — Walgreens and CVS have joined a growing list of retailers requesting customers not to bring guns into their stores. Both companies, as well as Wegmans Food Markets, announced that they were changing their policies on Thursday — two days after Walmart and Kroger joined the national gun debate by asking shoppers not